934
Views
7
CrossRef citations to date
0
Altmetric
Original Article

The associations of daylight and melatonin receptor 1B gene rs10830963 variant with glycemic traits: the prospective PPP-Botnia study

ORCID Icon, , , , , & show all
Pages 58-67 | Received 20 Aug 2018, Accepted 18 Dec 2018, Published online: 14 Feb 2019

References

  • Shore-Lorenti C, Brennan SL, Sanders KM, et al. Shining the light on sunshine: a systematic review of the influence of sun exposure on type 2 diabetes mellitus-related outcomes. Clin Endocrinol (Oxf). 2014;81:799–811.
  • Mavri A, Guzic-Salobir B, Salobir PB, et al. Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease. Blood Coagul Fibrinolysis. 2001;12:359–365.
  • Ishii H, Suzuki H, Baba T, et al. Seasonal variation of glycemic control in type 2 diabetic patients. Diab Care. 2001;24:1503.
  • Tseng C-L, Brimacombe M, Xie M, et al. Seasonal patterns in monthly hemoglobin A1c values. Am J Epidemiol. 2005;161:565–574.
  • Berglund L, Berne C, Svärdsudd K, et al. Seasonal variations of insulin sensitivity from a euglycemic insulin clamp in elderly men. Ups J Med Sci. 2012;117:35–40.
  • Chen S-H, Chuang S-Y, Lin K-C, et al. Community-based study on summer-winter difference in insulin resistance in Kin-Chen, Kinmen, Taiwan. J Chinese Med Assoc. 2008;71:619–627.
  • Dumont M, Benhaberou-Brun D, Paquet J. Profile of 24-h light exposure and circadian phase of melatonin secretion in night workers. J Biol Rhythms. 2001;16:502–511.
  • Pan A, Schernhammer ES, Sun Q, et al. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. Plos Med. 2011;8:e1001141.
  • Gan Y, Yang C, Tong X, et al. Shift work and diabetes mellitus: a meta-analysis of observational studies. Occup Environ Med. 2015;72:72–78.
  • Vetter C, Dashti HS, Lane JM, et al. Night shift work, genetic risk, and type 2 diabetes in the UK Biobank. Diabetes Care. 2018;41:762–769.
  • Waldhauser F, Dietzel M. Daily and annual rhythms in human melatonin secretion: role in puberty control. Ann N Y Acad Sci. 1985;453:205–214.
  • Haus E. Chronobiology in the endocrine system. Adv Drug Deliv Rev. 2007;59:985–1014.
  • Mulder H, Nagorny CLF, Lyssenko V, et al. Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene. Diabetologia. 2009;52:1240–1249.
  • McMullan CJ, Curhan GC, Schernhammer ES, et al. Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women. Am J Epidemiol. 2013;178:231–238.
  • Peschke E. Melatonin, endocrine pancreas and diabetes. J Pineal Res. 2008;44:26–40.
  • McMullan CJ, Schernhammer ES, Rimm EB, et al. Melatonin secretion and the incidence of type 2 diabetes. JAMA. 2013;309:1388–1396.
  • Rubio-Sastre P, Scheer FAJL, Gómez-Abellán P, et al. Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening. Sleep. 2014;37:1715–1719.
  • Tuomi T, Nagorny CLFLF, Singh P, et al. Increased melatonin signaling is a risk factor for type 2 diabetes. Cell Metab. 2016;23:1067–1077.
  • Hardeland R. Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment. Aging Dis. 2012;3:194–225.
  • Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009;41:77–81.
  • Jonsson A, Ladenvall C, Ahluwalia TS, et al. Effects of common genetic variants associated with type 2 diabetes and glycemic traits on α- and β-cell function and insulin action in humans. Diabetes. 2013;62:2978–2983.
  • Lyssenko V, Nagorny CL, Erdos MR, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet. 2009;41:82–88.
  • Langenberg C, Pascoe L, Mari A, et al. Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response. Diabetologia. 2009;52:1537–1542.
  • Sparso T, Bonnefond A, Andersson E, et al. G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans. Diabetes. 2009;58:1450–1456.
  • Gaulton KJ, Ferreira T, Lee Y, et al. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet. 2015;47:1415–1425.
  • Renström F, Koivula RW, Varga TV, et al. Season-dependent associations of circadian rhythm-regulating loci (CRY1, CRY2 and MTNR1B) and glucose homeostasis: the GLACIER Study. Diabetologia. 2015;58:997–1005.
  • Isomaa B, Forsen B, Lahti K, et al. A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study. Diabetologia. 2010;53:1709–1713.
  • Di Camillo B, Hakaste L, Sambo F, et al. HAPT2D: high accuracy of prediction of T2D with a model combining basic and advanced data depending on availability. Eur J Endocrinol. 2018;178:331–341.
  • Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419.
  • Bergman RN, Prager R, Volund A, et al. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 1987;79:790–800.
  • Hanson RL, Pratley RE, Bogardus C, et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol. 2000;151:190–198.
  • Bergman RN, Ader M, Huecking K, et al. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes. 2002;51(1):S212–S220.
  • Chen S-H, Jen I-A, Chuang S-Y, et al. Community-based study on summer-winter differences of component of metabolic syndrome in Kinmen, Taiwan. Prev Med. 2006;43:129–135.
  • Suarez L, Barrett-Connor E. Seasonal variation in fasting plasma glucose levels in man. Diabetologia. 1982;22:250–253.
  • Isken F, Abraham U, Weickert M, et al. Annual change in insulin sensitivity. Horm Metab Res. 2011;43:720–722.
  • Kemp DM, Ubeda M, Habener JF. Identification and functional characterization of melatonin Mel 1a receptors in pancreatic beta cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling. Mol Cell Endocrinol. 2002;191:157–166.
  • Peschke E, Bach AG, Muhlbauer E. Parallel signaling pathways of melatonin in the pancreatic beta-cell. J Pineal Res. 2006;40:184–191.
  • Gale JE, Cox HI, Qian J, et al. Disruption of circadian rhythms accelerates development of diabetes through pancreatic beta-cell loss and dysfunction. J Biol Rhythms. 2011;26:423–433.
  • Dibner C, Schibler U. Circadian timing of metabolism in animal models and humans. J Intern Med. 2015;277:513–527.
  • Morikawa Y, Nakagawa H, Miura K, et al. Shift work and the risk of diabetes mellitus among Japanese male factory workers. Scand J Work Environ Health. 2005;31:179–183.
  • Lane JM, Chang A-M, Bjonnes AC, et al. Impact of common diabetes risk variant in MTNR1B on sleep, circadian, and melatonin physiology. Diabetes. 2016;65:1741–1751.
  • Pyykkonen AJ, Isomaa B, Pesonen AK, et al. Sleep duration and insulin resistance in individuals without type 2 diabetes: the PPP-Botnia study. Ann Med. 2014;46:324–329.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.